Venue: Fundación Ramón Areces Madrid, Spain, October 22-23, 2015.
In colaboration with CIBERER-ISCIII Rare endocrine diseases are clinically and genetically heterogeneous, some are congenital; others are acquired in adult life. They determine many comorbidities that impair quality of life and social activities. Therapy requires a multidisciplinary approach, not only control of hormonal dysfunction. The principal challenges regarding rare endocrine diseases nowadays include:
1) The difficulty in clinical and molecular diagnosis.
2) A specific clinical multidisciplinary management.
3) Persistent comorbidities after endocrine “cure”.
4) Effective and safe therapies that can cure the disease and delay comorbidities, improving long-term prognosis.
This Symposium is devoted to new advances in clinical management and therapy in rare endocrine diseases, including national and international experts. There will also be patients’ associations, nurses and FEDER (Federación Española de Enfermedades Rara) members, making it more interactive and educational.